Cipla's gross revenue FY 2015-2024
The consolidated revenue of Cipla Limited for fiscal year 2024 was over 257 billion Indian rupees. This was a significant increase from the revenue in 2022 which stood at approximately 217 billion rupees.
Cipla Limited is an Indian pharmaceutical company which primarily develops medicine to treat respiratory, cardiovascular diseases, diabetes, arthritis, weight control and depression.